Values as of: 2025-05-02
ETF | Health |
Last Closing
USD 80.46Change
+1.49 (+1.89)%Market Cap
USD 0.16BVolume
0.04MAnalyst Target
N/AVerdict
Verdict
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).
Company Website : http://www.spdrs.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| XLV | Health Care Select Sector SPDR.. |
+1.89 (+1.38%) |
USD 35.08B |
| FHLC | Fidelity® MSCI Health Care In.. |
+0.95 (+1.48%) |
USD 2.50B |
| FXH | First Trust Health Care AlphaD.. |
+1.20 (+1.21%) |
USD 0.89B |
| IDNA | iShares Genomics Immunology an.. |
+0.39 (+1.89%) |
USD 0.10B |
| XHS | SPDR® S&P Health Care Service.. |
+1.39 (+1.45%) |
USD 0.09B |
| SBIO | ALPS Medical Breakthroughs ETF |
+0.27 (+0.90%) |
USD 0.08B |
| HTEC | Robo Global® Healthcare Techn.. |
+0.74 (+2.77%) |
USD 0.04B |
| BBP | Virtus LifeSci Biotech Product.. |
-0.42 (-0.71%) |
USD 0.02B |
| BBC | Virtus LifeSci Biotech Clinica.. |
+0.47 (+2.46%) |
USD 0.01B |
| IHE | iShares U.S. Pharmaceuticals E.. |
+1.40 (+2.14%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| INAV | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Health) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -9.10% | 14% | F | 23% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -9.10% | 14% | F | 22% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -6.43% | 24% | F | 29% | F | ||
| Dividend Return | 0.04% | 13% | F | N/A | F | ||
| Total Return | -6.39% | 24% | F | 24% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -1.37% | 24% | F | 31% | F | ||
| Dividend Return | 0.12% | 11% | F | N/A | F | ||
| Total Return | -1.25% | 24% | F | 16% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -4.22% | 24% | F | 17% | F | ||
| Dividend Return | -4.21% | 19% | F | 11% | F | ||
| Total Return | 0.01% | 5% | F | 1% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 21.07% | 38% | F | 48% | F | ||
| Risk Adjusted Return | -19.97% | 24% | F | 12% | F | ||
| Market Capitalization | 0.16B | 70% | C- | 33% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
